Reuters logo
BRIEF-Clearside Biomedical provides update on diabetic macular edema trial
April 20, 2017 / 12:33 PM / 5 months ago

BRIEF-Clearside Biomedical provides update on diabetic macular edema trial

April 20 (Reuters) - Clearside Biomedical Inc

* Clearside biomedical, inc. Announces completion of patient enrollment in phase 1/2 open label clinical trial of cls-ta in diabetic macular edema

* Currently expects to report preliminary results from exploratory clinical trial of cls-ta in second half of 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below